Shimal Research Laboratories Limited
About Shimal Research Laboratories Limited
Data last updated:
Shimal Research Laboratories Limited is a public limited company based in New Delhi, Delhi, India, a subsidiary of Oscar Investments Limited. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 12 January 2001.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U73100DL2001PLC109185.
The company has an authorised share capital of ₹40 Cr and a paid-up capital of ₹37.49 Cr. It is led by directors including Pradeep Kumar Shukla and Prakash Mishra.
Its last annual general meeting (AGM) was held on 27 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at G – 16 Marina Arcade Connaught Circus, New Delhi, Delhi, India – 110001.
Its group structure includes 1 subsidiary.
The company has 1 deal on record (1 acquisition); the latest was in May 2008.
Company details
CIN history
Shimal Research Laboratories has one previous CIN (Corporate Identification Number): U73100DL2001PTC109185. The current CIN is U73100DL2001PLC109185, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100DL2001PLC109185 | Current |
| U73100DL2001PTC109185 | Previous |
Contact details
Shimal Research Laboratories Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressG – 16 Marina Arcade Connaught Circus, New Delhi, Delhi, India – 110001
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Shimal Research Laboratories Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shimal Research Laboratories is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
Financials of Shimal Research Laboratories Limited
FY 2018 filings availableShimal Research Laboratories Limited reported revenue of ₹4,000 (down 100% YoY) for FY 2016.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 85% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ₹4,000 | |
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Shimal Research Laboratories Limited, buy the company report.
Board of directors of Shimal Research Laboratories Limited
Shimal Research Laboratories has 3 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pradeep Kumar Shukla | Director | 02 Apr 2018 | 8 Years 6 Months | Current |
| Prakash Mishra Also directs: Oscar Investments Limited | Director | 27 Aug 2018 | 8 Years 2 Months | Current |
| Sanjeev Kumar Singhal Also directs: Anr Securities Private Limited | Director | 28 Nov 2011 | 14 Years 10 Months | Current |
Auditor
Shimal Research Laboratories Limited is audited by S R BAGAI & CO for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R BAGAI & CO | FY 2016 | 002388N |
Shareholding
The shareholding of Shimal Research Laboratories Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Shimal Research Laboratories Limited, buy the company report.
Deals & funding
Shimal Research Laboratories Limited has 1 deal on record (1 acquisition); the latest was in May 2008.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2008 | Acquisition | ₹94.2 Cr | Buyer: Ranbaxy Laboratories Ltd |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Shimal Research Laboratories Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shimal Research Laboratories Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Shimal Research Laboratories has 1 subsidiary company. This group structure data is as of FY 2017. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Fortis Clinical Research Limited | U73100DL2005PLC134482 |
To see the full group structure of Shimal Research Laboratories Limited, buy the company report.
GST
No GST registration is on our record for Shimal Research Laboratories Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Shimal Research Laboratories Limited has 16 board changes on record since 2008: 3 appointments and 13 cessations. The latest: Pradeep Kumar Shukla ceased to be Additional Director on 27 Sep 2018.
7 earlier events are in the company report.
Frequently asked questions
Shimal Research Laboratories is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Shimal Research Laboratories is a company pending strike off, currently registered as a public limited company based in New Delhi, Delhi, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 12 January 2001 and is registered under CIN U73100DL2001PLC109185. The company may be struck off soon - caution is advised.
The compliance status of Shimal Research Laboratories is active non-compliant as of 21 September 2026.
Shimal Research Laboratories has 3 current directors:
- Pradeep Kumar Shukla - Director
- Prakash Mishra - Director
- Sanjeev Kumar Singhal - Director
The CIN (Corporate Identification Number) of Shimal Research Laboratories is U73100DL2001PLC109185. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shimal Research Laboratories was incorporated on 12 January 2001. It is registered with the Registrar of Companies, Delhi.
The registered office of Shimal Research Laboratories is at G – 16 Marina Arcade Connaught Circus, New Delhi, Delhi, India – 110001.
The latest financial statements of Shimal Research Laboratories on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 27 September 2018. Year-wise statements from 2015 are in the company report.
Shimal Research Laboratories operates in the pharma industry, in the pharma contract r and d segment.
Shimal Research Laboratories has 1 deal on record (1 acquisition); the latest was in May 2008.